India: Zenex Improved Animal Health and Welfare Project
The project is an equity investment in India's second largest animal health company. ADB's investment proceeds will be used by ZAHL for working capital, maintenance capex and research and development purposes, including for new product development.
Request for information
- Agriculture, natural resources and rural development
|Project Name||Zenex Improved Animal Health and Welfare Project|
|Borrower/Company||Zenex Animal Health India Private Limited
|Type or Modality of Assistance||
|Strategic Agendas||Inclusive economic growth
|Drivers of Change||Private sector development
|Sector / Subsector||
Agriculture, natural resources and rural development / Agricultural production
|Gender Equity and Mainstreaming||Effective gender mainstreaming|
|Responsible ADB Department|
|Responsible ADB Division|
|Responsible ADB Officer||Dora, Tushna|
|Description||The project is an equity investment in India's second largest animal health company. ADB's investment proceeds will be used by ZAHL for working capital, maintenance capex and research and development purposes, including for new product development.|
|Objectives and Scope||The project will support the enhanced production of quality animal healthcare products, which will help small holder farmers to mitigate disease risk, reduce losses and increase productivity, thereby increasing farmers' incomes. The project will also support increased awareness about antimicrobial resistance, better farm hygiene and biosecurity best practices. The project will also support gender inclusion at corporate and farm level. It is fully aligned with the Government of India goal of boosting agricultural productivity and farmers' incomes.|
|Linkage to Country/Regional Strategy||
The project is consistent with ADB's Strategy 2030 and four of its operational priorities (OP): OP1 by improving the incomes of farmers and improving health outcomes for all; OP2 by promoting gender equality through the action plan; OP5 by providing farmers with quality farm inputs to improve agricultural production, and OP7 by using regional cooperation for cross-border communicable disease prevention and facilitating trade.
The project is also aligned with ADB's Operational Plan for Private Sector Operations, 2019 to 2024, which calls for focusing on and mobilizing funds for providers of agricultural inputs and improving quality standards in upstream sectors and with the country partnership strategy, 2018 to 2022 for India, which supports investments to improve agricultural productivity. The country partnership strategy also states that ADB will focus on the government's priority of doubling farmers incomes, and provide support to intensify and diversify agricultural production. The project also complements other ADB sovereign initiatives, namely: (i) East Asia Regional Departments Long-term Greater Mekong Subregion (GMS) Strategic Framework 2030 and GMS Health Cooperation Strategy 2019 to 2023, (ii) South Asia Regional Departments (SARD) Regional Project Development Support for the South Asia Subregional Economic Cooperation Operational Plan, 2016 to 2025 One Health, (iii) SARDs Scoping Study on One Health.
|Summary of Environmental and Social Aspects|
|Environmental Aspects||The project is classified as category B for environment. The categorization is based on the potential environmental and social impacts of the existing operations of Zydus (being the entity from whom ZAHL acquired the Animal Health Business) and the future animal healthcare business activities to be undertaken by ZAHL.|
|Involuntary Resettlement||The project is classified as category C for involuntary resettlement and indigenous peoples.|
|Indigenous Peoples||The project is classified as category C for indigenous peoples.|
|Stakeholder Communication, Participation, and Consultation|
|Timetable for assistance design, processing and implementation|
|Credit Committee Meeting||-|
|Approval||19 Nov 2021|
|Last PDS Update||19 Nov 2021|
Project Data Sheets (PDS) contain summary information on the project or program. Because the PDS is a work in progress, some information may not be included in its initial version but will be added as it becomes available. Information about proposed projects is tentative and indicative.
The Access to Information Policy (AIP) recognizes that transparency and accountability are essential to development effectiveness. It establishes the disclosure requirements for documents and information ADB produces or requires to be produced.
The Accountability Mechanism provides a forum where people adversely affected by ADB-assisted projects can voice and seek solutions to their problems and report alleged noncompliance of ADB's operational policies and procedures.
In preparing any country program or strategy, financing any project, or by making any designation of, or reference to, a particular territory or geographic area in this document, the Asian Development Bank does not intend to make any judgments as to the legal or other status of any territory or area.
|Title||Document Type||Document Date|
|Zenex Improved Animal Health and Welfare Project: Report and Recommendation of the President||Reports and Recommendations of the President||Oct 2021|
|Zenex - Improved Animal Health and Welfare Project: Initial Poverty and Social Analysis||Initial Poverty and Social Analysis||Sep 2021|
Safeguard Documents See also: Safeguards
Safeguard documents provided at the time of project/facility approval may also be found in the list of linked documents provided with the Report and Recommendation of the President.
None currently available.
Evaluation Documents See also: Independent Evaluation
None currently available.
None currently available.
The Access to Information Policy (AIP) establishes the disclosure requirements for documents and information ADB produces or requires to be produced in its operations to facilitate stakeholder participation in ADB's decision-making. For more information, refer to the Safeguard Policy Statement, Operations Manual F1, and Operations Manual L3.
Requests for information may also be directed to the InfoUnit.
ADB Invests in Zenex Animal Health to Boost Livestock Farmer Income and Contain Antimicrobial ResistanceADB and Zenex Animal Health India Private Limited today signed an agreement for an investment by ADB of up to $10 million to increase ZAHL’s production and distribution of quality animal health care products and help boost farmer...